SHANGHAI PHARMACEUTICALS HOLDING CO., LTD

Highlights Shanghai Pharmaceuticals Holding Co., Ltd

Equities

601607

CNE000000C82

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-16 pm EDT			5-day change	1st Jan Change
18.46 ^CNY	0.00%		+1.93%	+10.34%

May. 14	Shanghai Pharmaceuticals Unit Gets Green Light to Market Cancer Drug	MT
May. 14	Shanghai Pharmaceuticals Gets Regulatory Nod to Trial Tumor Drug	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Shanghai Pharmaceuticals Unit Gets Green Light to Market Cancer Drug	May. 14	MT
Shanghai Pharmaceuticals Gets Regulatory Nod to Trial Tumor Drug	May. 14	MT
Shanghai Pharmaceuticals Holding's Q1 Profit Rises 2% as Revenue Grows 6%	Apr. 29	MT
Shanghai Pharmaceuticals Holding Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Shanghai Pharma's Profit Plunges 33% in 2023 Despite 12% Revenue Growth; Shanghai Shares Rise 4%	Apr. 01	MT
Shanghai Pharmaceuticals Holding Co., Ltd Proposes Final Dividend for the Year Ended 31 December 2023, Payable Before 30 August 2024	Mar. 28	CI
Shanghai Pharmaceuticals Holding Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
Shanghai Pharmaceuticals Gets Nod to Register Amiodarone Hydrochloride Injection	Mar. 22	MT
Shanghai Pharma Unit's Citicoline Sodium Injection Passes Regulatory Evaluation	Mar. 08	MT
Shanghai Pharmaceuticals Holding Gets Fine for Anti-Monopoly Violations	Dec. 17	MT
Shanghai Pharma's Ex-Vice President Becomes Sixth Senior Exec to Face Probe	Nov. 23	MT
Shanghai Pharmaceuticals' Profit Up 6% in Q3	23-10-27	MT
Shanghai Pharmaceuticals Holding Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
Shanghai Pharma’s Arthrits Drug Passes Generic Drug Consistency Test	23-10-05	MT
Shanghai Pharma’s Former Execs Face Probe	23-09-04	MT
Shanghai Pharmaceuticals’ H1 Profit Slides 29% Despite 19% Revenue Growth; Shanghai Shares Slump 8%	23-08-30	MT
Shanghai Pharmaceuticals Holding Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-23	CI
Ex-dividend day for final dividend	23-07-19	FA
Shanghai Pharmaceuticals Holding Co., Ltd. Approves a Cash Dividend on H Share for year 2022, Expected Payable on 28 August 2023	23-06-29	CI
Shanghai Pharma Unit Gets Greenlight to Produce Active Ingredient in AIDS Medicine	23-05-18	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Shanghai Pharmaceuticals Holding Co., Ltd

Equities

601607

CNE000000C82

Highlights

Filters